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Background: The underlying mechanisms of the exercise-induced increase in cardiac 2 
troponins (cTn) are poorly understood. The aim of this study was to identify independent 3 
determinants of exercise-induced cTn increase in a large cohort of healthy recreational 4 
athletes.  5 
Methods: A total of 1002 recreational cyclists without known cardiovascular disease or 6 
medication, participating in a 91-km mountain bike race were included. Median age was 47 7 
years and 78% were males. Blood samples were obtained 24 hours prior to, and 3 and 24 8 
hours after the race.  9 
Results: Cardiac TnI concentrations increased markedly from baseline [1.9 (1.6-3.0) ng/L] to 10 
3 hours after the race [52.1 (32.4-91.8) ng/L], declining at 24 hours after the race [9.9 (6.0-11 
20.0) ng/L]. Similarly, cTnT increased from baseline [3.0 (3.0-4.2) ng/L] to 3 hours after the 12 
race [35.6 (24.4-54.4) ng/L], followed by a decline at 24 hours after the race [10.0 (6.9-15.6) 13 
ng/L]. The 99th percentile was exceeded at 3 hours after the race in 84% (n=842) of subjects 14 
using the cTnI assay and in 92% (n=925) of study subjects using the cTnT assay. Shorter race 15 
duration and higher systolic blood pressure (SBP) at baseline were highly significant 16 
(p<0.001) independent predictors of exercise-induced cTn increase both in bivariate and 17 
multivariable analysis. The age, gender, body mass index, training experience and 18 
cardiovascular risk of participants were found to be less consistent predictors.  19 
Conclusion: Systolic blood pressure and race duration were consistent predictors of the 20 
exercise-induced cTn increase. These variables likely reflect important mechanisms involved 21 
in the exercise-induced cTn elevation.  22 
 23 
Trial registration number: NCT02166216 https://clinicaltrials.gov/ct2/show/NCT02166216 24 




1.0 Introduction 1 
The “Fourth definition of myocardial infarction” defines a rise and fall pattern of cardiac 2 
troponin (cTn) above the 99th percentile as myocardial injury (1). However, following 3 
strenuous exercise there is a rise and fall pattern in cTn in healthy subjects without evidence 4 
of irreversible myocardial impairment (2). Most researchers therefore consider the cTn 5 
increase in relation to exercise to be a physiological response (2-5). The underlying 6 
mechanisms and determinants of the exercise-induced cTn increase in healthy individuals are 7 
poorly understood.  It has been hypothesized that cTn can be released due to reversible 8 
myocyte injury and stretch-induced apoptosis, or increased membrane permeability with 9 
leakage of loosely bound cTn (2,6). Exercise-induced troponin increase has also been thought 10 
to be due to increased wall tension and ventricular strain caused by volume overload, neuro-11 
hormonal stimulation and/or reversible ischaemia due to increased myocardial energy 12 
demands (2,7). Several studies have attempted to identify predictors of the exercise-induced 13 
cTn release; however, most of these studies are small, sampled cTn only immediately after 14 
exercise or used older cTn assays. Findings from these studies are conflicting, both regarding 15 
the influence of age, gender, blood pressure, body composition, training experience and the 16 
influence of cardiovascular risk factors (2,4,8-13).  17 
In this large-scale prospective observational study, the aim was to identify the most important 18 
predictors associated with the cTn response following strenuous exercise, using high-19 
sensitivity cTnI and cTnT assays.   20 
 21 




2.0 Methods 1 
2.1 Design and study population 2 
This prospective, observational biomarker-study included recreational cyclists ≥ 16 years of 3 
age, residing in Norway without any previous or known CV disease. Subjects were excluded 4 
if they reported any CV symptoms, CV treatment or disease (including coronary artery 5 
disease, stroke, diabetes mellitus or hypertension requiring treatment). All electrocardiograms 6 
(ECGs) were interpreted by experienced cardiologists, and participants were excluded if the 7 
ECG had signs of underlying CV disease: Q-waves (>3mm in depth or > 40 ms in duration in 8 
two or more leads except III, aVR and V1), T-inversions (>1 mm in depth in two or more 9 
leads in V2-6, II and aVF, or I and aVL), left bundle branch block or atrial or ventricular 10 
tachyarrhythmias. Subjects were excluded from this analysis if they did not complete all study 11 
assessments. The study was approved by the Regional Ethics Committee (REK 2013/550), 12 
and complies with the Declaration of Helsinki. All participants signed informed consent forms 13 
prior to enrolment into the study. In total, 1002 participants were included in the present 14 
analysis (Supplementary Figure 1).  15 
2.2 Data collection 16 
An extensive logistic system was developed to allow a comprehensive 30 min assessment of 17 
each of the more than 1000 study subjects 24 hours before the race, and at 3 and 24 hours 18 
following the race (Supplementary Figure 2). The assessments included ECG, blood pressure 19 
measurements, body weight and blood sampling. Detailed clinical information was obtained 5 20 
times by digital questionnaires (Adobe FormsCentral, Adobe Systems Software Ireland Ltd., 21 
Ireland). Start- and finishing times were recorded for all participants by the organizer of the 22 
race. Subjects reported heart rate data from personal sport watches if available. Age adjusted 23 




2.3 Blood samples  1 
Venous blood samples were drawn from the antecubital vein. Cardiac TnI in serum was 2 
analyzed within 24 hours at Stavanger University Hospital on an Architect i2000SR using the 3 
high-sensitive cTnI STAT assay from Abbott Diagnostics (Abbott Diagnostics, IL, USA).  4 
Frozen samples were transported on dry ice to Haukeland University Hospital, Bergen, and 5 
cTnT was analysed using a high-sensitivity cTnT assay on Cobas e601 (Roche Diagnostics, 6 
Switzerland) in serum that had not been previously thawed. The cTnI assay has a limit of 7 
detection of 1.6 g/L, and the overall 99th percentile of the assay is at 26 ng/L (females: 22 8 
ng/L, males 28 ng/L). The cTnT assay had a limit of blank of 3 ng/L, and a 99th percentile of 9 
14 ng/L (females: 10 ng/L, males 16 ng/L) (15). Subjects with cTnI values ≤ 1.6 ng/L (n=403 10 
at baseline, n=0 at 3h, n=13 at 24h) were given the value 1.6. Subjects with cTnT values 11 
below 3 ng/L (n=582 at baseline, n=2 at 3h, n=31 at 24h) were given the value of 3 ng/L.  12 
2.4 Statistical analysis 13 
Normally distributed variables are reported as mean ±SD, while continuous variables with 14 
markedly skewed distributions are reported as median and (25th percentile - 75th percentile). 15 
The Shapiro-Wilk test was used to test for normality. A two-tailed p-value of < 0.05 was 16 
considered significant. Bivariate correlations between the cTn assays and between cTn and 17 
variables previously suggested to be associated with exercise-induced cTn release was 18 
assessed at baseline, 3- and 24 hours after the race using Spearman’s rank correlation. 19 
Multiple linear regression analysis was used to identify predictors of the cTn response to 20 
exercise at each sampling time-point, using a backward variable elimination procedure. The 21 
following variables were included in the models: gender, age, resting heart rate, baseline 22 
systolic- and diastolic blood pressure, low density lipoprotein (LDL), estimated glomerular 23 
filtration rate (eGFRCKD-EPI), body mass index (BMI), race duration, Framingham risk score 24 




the dependent variables. Additional multiple regression analysis was performed in the cohort 1 
who reported data from personal sport watches (n=551), and for delta cTn values, including 2 
the same variables as mentioned above. For categorical variables, difference in cTn was 3 
assessed by the Mann-Whitney U test. For statistical analyses, the statistical software 4 
programs SPSS version 24 and GraphPad Prism 7 were used.  5 




3.0 Results 1 
Participants were 46.8 (40.1-52.6) years old, 78.2% were male (Table 1). Race duration was 2 
3.7 (3.4-4.2) hours. None of the subjects included in this study reported CV symptoms during 3 
or following the race.  4 
3.1 Cardiac troponin kinetics 5 
The distributions of cTn values at baseline and at 3- and 24 hours after the race are shown in 6 
Figure 1. At baseline, a total of 40.2 % (cTnI) and 58.1 % (cTnT) had cTn values below the 7 
limit of detection (Table 1, Figure 1).  Cardiac TnI concentrations increased markedly from 8 
baseline [1.9 (1.6-3.0) ng/L] to 3 hours after the race [52.1 (32.4-91.8) ng/L], declining at 24 9 
hours after the race [9.9 (6.0-20.0) ng/L]. Similarly, cTnT increased from baseline [3.0 (3.0-10 
4.2) ng/L] to 3 hours after the race [35.6 (24.4-54.4) ng/L], followed by a decline at 24 hours 11 
after the race [10.0 (6.9-15.6) ng/L]. Due to the skewed cTn distribution, mean cTn values 12 
were higher at all time-points, and are outlined in Supplementary Table 1. Cardiac TnI values 13 
exceeded the 99th percentile (26 ng/L) in 84% of study subjects at 3 hours and 18% at 24 14 
hours following the race. Cardiac TnT values exceeded the 99th percentile (14 ng/L) in 92% 15 
of study subjects at 3 hours, and 30% at 24 hours following the race. Delta cTnI between 3 16 
hours post-race and baseline (∆cTnI 3-0h) was 49.9 (29.4-87.0) ng/L. Delta cTnT (∆cTnT 3-17 
0h) was 31.7 (20.6-50.1) ng/L. Cardiac troponin values at 24 hours after the race were also 18 
higher than baseline levels in virtually all subjects; ∆cTnI 24h-0h: 7.4 (3.7-16.5) ng/L, ∆cTnT 19 
24h-0h: 6.3 (3.3-11.1) ng/L, all p<0.001. 20 
The correlation between cTnI and cTnT at baseline was moderate (rho=0.60, p<0.001), likely 21 
due to a high number of subjects with cTn values below the limit of detection. At 3- and 24 22 
hours after the race, the correlation was closer (3h: rho=0.87, p<0.001, 24h: rho=0.76, 23 




3.2 Factors associated with cTn levels at baseline and following exercise   1 
Baseline systolic blood pressure and race duration were consistently related to both cTnI and 2 
cTnT at all time-points following the race both in bivariate and multivariable models (Table 3 
2). At baseline age, systolic- and diastolic blood pressure, BMI, body weight, waist 4 
circumference, Framingham risk score and LDL-levels were positively correlated with cTn, 5 
while resting heart rate, race duration, mean heart rate during the race, and eGFR were 6 
negatively correlated (Table 2). A similar pattern was detected for correlations with cTn at 24 7 
hours after the race.  8 
Age was inversely associated with the cTnI response at 3 hours after the race, but positively 9 
correlated at baseline and 24 hours after the race.   10 
A total of 219 females (22%) were included into the analysis. Female participants were 11 
younger than the male cohort (45.7 (38.8-51.1) versus 47.2 (40.3-53.2) years, p=0.022). They 12 
also had lower systolic blood pressure (127 (120-140) vs 138 (129-150) mmHg, p<0.001), 13 
lower BMI (23.8 (22.2-25.8) vs 25.6 (24.3-27.6) kg/m2, p<0.001), and they finished the race 14 
0.8 hours slower than their male counterparts (4.5 (4.0-5.0) vs 3.7 (3.3-4.0) hours, p<0.001).  15 
Both cTnI and cTnT were significantly higher in male as compared with female cyclists both 16 
at baseline and at 24 hours after the race. At 3 hours after the race, male participants had 17 
significantly higher cTnT but not cTnI values. The number of participants who exceeded the 18 
sex-specific 99th percentile at all time-points was similar for both genders (Supplementary 19 
Table 2). Female gender remained a significant predictor for higher cTnI 3 hours after the 20 
race (B=-0.27, p=0.002), but not for cTnT. At 24 hours after the race, gender was a borderline 21 
significant predictor of the cTnT (B=0.09, p=0.096), but not the cTnI response. 22 
Baseline cTn values were closely associated with the post-exercise cTn values in multiple 23 




hours after the race and from baseline to 24 hours after the race was performed, and systolic 1 
blood pressure and race duration remained independent predictors of the cTn increase in these 2 
models (Supplementary Table 3).  3 
Only 55% (n=551) reported heart rate data from personal sport watches, and heart rate 4 
variables were therefore not included in the multiple regression models. An analysis that 5 
included the variable “mean heart rate during the race” was performed in the cohort with heart 6 
rate data. In this model, the associations between mean heart rate during the race and cTnI at 7 
3-hour post-race (B=0.004, p=0.077) and with cTnT 24 hours post-race (B=0.003, p=0.028) 8 
were borderline significant. Mean heart rate did not remain a significant predictor for cTnT 3 9 
hour post-race or cTnI 24 hours after the race.  10 
Levels of low-density lipoprotein cholesterol (LDL-C) at baseline were not associated with 11 
the cTn response at either 3 or 24 hours after the race, nor were the Framingham risk score 12 
(Table 2). A total of 31 subjects reported a first degree relative with premature cardiovascular 13 
disease (<50 years of age). These subjects did not have a different cTn response than the rest 14 
of the cohort. Subjects above the age of 35 years that fulfilled the High-Risk criteria proposed 15 
for recreational athletes (n=238, 23.8 %) were also assessed separately. Increased BMI was 16 
the most common cause for High-Risk classification (n=183, 76.9 %, Supplementary Figure 17 
3). High-Risk individuals had similar levels of cTn at 3 hours after the race and higher cTn 18 
levels at 24 hours post-race (cTnI: 12.3 (6.8-25.6) vs 9.6 (5.9-18.6) ng/L, p=0.001, cTnT: 11.5 19 
(7.8-18.5) vs 9.9 (6.7-15.0) ng/L, p<0.001, Supplementary Figure 4).  20 
Some of the included subjects reported several co-morbidities and intake of different 21 
supplements. (Supplementary Table 4-5): 31.8 % of subjects (n=319) reported to use 22 
supplements regularly, while 27.7% of subjects (n=278) never used supplements. There were 23 




4.0 Discussion 1 
This is the largest study ever performed to determine the predictors of the exercise-induced 2 
cTn response. Troponin levels increased in all subjects, with more than 84% of subjects 3 
exceeding the 99th percentile of the cTn assays at three hours following exercise. At 24 hours 4 
18-30 % of subjects still had cTn levels above the 99th percentile. Systolic blood pressure and 5 
race duration were consistent predictors of cTnT and cTnI levels at all time-points following 6 
exercise. Other previously suggested variables were less consistently associated with the cTn 7 
increase. The strength of this study is the large number of study subjects, allowing the 8 
inclusion of all previously suggested predictors of the exercise-induced cTn increase, the use 9 
of two different high-sensitivity cTn assays, and multiple cTn sample time-points. However, 10 
despite the large sample size allowing inclusion of all previously suggested predictors, the 11 
post-race multiple regression models only explained a variance of 15-36 % of cTn levels 12 
following exercise. Considering this, the present study shows that additional unidentified 13 
factors are involved in and needed to improve the prediction and understanding of the 14 
exercise-induced cTn response.  15 
4.1 Exercise-induced cTn elevation  16 
There is limited understanding of the underlying mechanisms of the physiological cTn 17 
increase following exercise. A leading current hypothesis is that stress can cause reversible 18 
cardiac injury leading to cell wounds, cytoplasmatic blebbing, and the release of intracellular 19 
macromolecules, as well as activation of apoptosis (6). Irreversible injury with necrosis of 20 
cardiomyocytes and degradation of cTn by lysosomal enzymes are however, difficult to 21 
distinguish from the reversible causes based on systemic cTn levels alone, and current 22 
imaging modalities lack the sensitivity to identify non-focal necrosis (6). Several mechanisms 23 




can be released due to exercise-induced increase in wall tension and ventricular strain, neuro-1 
hormonal stimulation and/or reversible ischemia due to increased myocardial energy demand 2 
(2,6,7).  3 
The present study demonstrates an increase in both cTnI and cTnT in all subjects following 4 
strenuous exercise. This finding supports that exercise-induced cTn increase in healthy 5 
subjects is a physiological response.  6 
4.2 Exercise intensity and duration 7 
In this study, there was a consistent inverse relation between cTn levels and race duration in 8 
both bivariate and multiple regression models (Table 2, Supplementary Table 3). Previous 9 
studies assessing the relationship between the cTn response and race duration have been 10 
conflicting: Some studies found a direct correlation (3,16,17), whereas others found an 11 
inverse correlation (4,13) or no correlation (11,12,18). Although race duration is a readily 12 
available parameter, the interpretation of this variable is complex. Race duration is related to 13 
physical fitness (19). However, it also reflects sport specific technical skills, exercise intensity 14 
and the duration of high-intensity work. Shorter race duration requires higher velocity, which 15 
necessitates higher exercise intensity. Exercise intensity and the duration of high-intensity 16 
work are important predictors of the exercise-induced cTn response. The intensity of the work 17 
required to induce a significant increase in the exercise-induced cTn response has recently 18 
been addressed by Stewart et al. (20). In their study, a marked increase in exercise-induced 19 
cTn was found following a 90 min ergometer cycling test, when exercise was performed with 20 
an exercise intensity above the gas exchange threshold. The present population-based study 21 
and the mechanistic study by Stewart et al. underscore the importance of the intensity-22 





4.3 Systolic blood pressure  1 
A major finding of the present study was the consistent relationship between systolic blood 2 
pressure measured prior to the race and cTn elevations both at 3- and 24 hours after the race. 3 
Systolic blood pressure has not been included in the multiple regression analyses in previous 4 
studies (10,12,13). However, some smaller studies have reported bivariate correlations 5 
between blood pressure and exercise-induced cTn increase (21,22). Our finding is intriguing, 6 
and in line with the recent mechanistic study by Weil and al., that observed a transient 7 
increase in cTnI following phenylepinephrine infusion in a pig model (7). The 8 
phenylepinephrine infusion caused increased systolic blood pressure and increased left 9 
ventricular end diastolic pressure in the absence of ischaemia. Our findings and the 10 
mechanistic work by Weil et al., suggest that the exercise-induced cTn increase in healthy 11 
subjects is related to increase in cardiac work, both in response to mechanical work and 12 
potentially due to increased neuro-hormonal activity induced by strenuous physical exercise 13 
and the competitive situation.  14 
4.4 Body composition  15 
The present study found inconsistent correlations between cTn and BMI, body weight and 16 
waist circumference at 3- and 24 hours after the race. There are conflicting reports on the 17 
relationship between cTn and BMI underscoring the complexity of this association; Eijsvogels 18 
et al. found no significant association with exercise-induced cTn increase (9), while a meta-19 
regression analysis found increased body weight to be a major predictor (4). BMI was 20 
originally established to measure tissue mass and obesity (23). However, BMI does not reflect 21 
body tissue composition. In a healthy athletic population, increased weight may reflect a 22 
higher muscular proportion compared with a larger proportion of adipose tissue in a sedentary 23 
population (24). Increased BMI may increase work load during physical exercise and thereby 24 




between BMI and exercise-induced cTn response, however requires careful interpretations, 1 
particularly in relation to a potential collinearity between body weight and performance (4). 2 
Waist circumference was also used to assess the potential impact of body composition on the 3 
exercise-induced cTn response. Waist circumference did not provide additional benefit 4 
compared with BMI in the prediction of the exercise-induced cTn increase.  5 
4.5 Age and gender 6 
Following exercise there was no clear relationship between age and cTn levels. These 7 
inconsistent results are in line with previous studies  that present conflicting data on the 8 
relationship between age and the exercise-induced cTn release: some studies indicate 9 
increased cTn levels in younger subjects (11-13), some studies indicate increased cTn levels 10 
in older athletes (10,25), whereas others report no correlations (26,27). Our study suggests 11 
that age is not a major independent predictor of exercise-induced cTn increase. However, 12 
since only 61 subjects (6.1 %) were above 60 years of age, future studies will need to confirm 13 
our findings in subjects above middle-age. 14 
Women have lower cTn levels at baseline than men, and gender-specific cTn cut-off values 15 
have been proposed. Gender differences have also been found to influence the exercise-16 
induced cTn release in some studies (11,28). In our cohort, the number of subjects who 17 
exceeded the gender-specific cTn cut-off at all time-points was similar for male and female 18 
participants, and the cTn distributions were fairly equal (Figure 1, Supplementary Table 2). In 19 
multiple regression analysis, however, females were found to have a higher cTnI increase as 20 
compared to men at 3 hours after the race when adjusted for other variables. This finding was 21 
not identified for the cTnT assay.    22 
4.6 Training experience  23 
Training experience has been found to be inversely associated with post-exercise cTn in 24 




condition. Training and competitive experience was measured as number of years of 1 
endurance training and number of endurance exercise competitions during the past five years. 2 
No significant association was found between this measure and cTn levels. The International 3 
Physical Activity Questionnaire (IPAQ) was used to assess the amount of exercise prior to the 4 
race. No relation was found between this measure and exercise-induced cTn. Our findings 5 
argue against a major relationship between training experience and cTn response.  6 
4.7 Other cardiovascular risk factors 7 
CV risk factors like cholesterol levels, family history of premature CV disease and 8 
Framingham risk were not found to significantly affect the exercise-induced cTn increase.  9 
The ESC sports cardiology group has proposed specific criteria for identifying recreational 10 
athletes above 35 years of age at increased risk of sport-related cardiac events (29). Using the 11 
proposed criteria, a total of 238 (23.8 %) of our participants were classified as High-Risk 12 
individuals due to the presence of at least one CV risk factor. A higher cTn level 24 hours 13 
after the race was identified in this High-risk group (p<0.01, Supplementary Figure 4). The 14 
clinical implications of this finding remain to be determined.  15 
4.8 Limitations 16 
There are some limitations that apply to the current study: First, with this large sample size, it 17 
was impossible to include mechanistic data beyond biomarkers and biometrics acquired 18 
during the study. The major limitations therefore relate to the lack of mechanistic data such as 19 
echocardiographic and ischemia assessment. Second, the present cohort was primarily 20 
middle-aged male subjects, and the findings may therefore not apply in a very young (<20 21 
years of age) or an above middle aged (>60 year of age) population. Third, undiagnosed 22 
coronary artery disease may be prevalent in this population. The impact of coronary artery 23 




implications of the current findings need to be determined. The clinical implications will be 1 
assessed by pre-specified follow-up studies at 5-, 10- and 20 years following inclusion. Fifth, the 2 
present cohort consisted of recreational athletes with a higher fitness level compared with the 3 
general population. The impact of cardiovascular adaptations to long-term physical activity, i.e. 4 
athlete’s heart, on exercise-induced cTn increase was not assessed in the present study. Sixth, the 5 
number of female subjects included in this study is much lower than the number of male 6 
subjects. This should be considered when interpreting the results on sex-specific cTn results. 7 
Seventh, heart rate data was based upon self-reported sport watch measurements from study 8 
subjects. Data variability between different brands was not considered.  9 
5.0 Conclusion 10 
In this large-scale prospective observational study, systolic blood pressure and race duration 11 
were consistent predictors of the exercise-induced cTn increase. These variables were more 12 
important than previously reported predictors of the exercise-induced cTn increase, such as 13 
body mass index, age, gender or training experience.  14 
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Figure legends 1 
Figure 1 2 
Distribution of cTn at baseline, and at 3- and 24 hours after the race, red indicates female 3 









Figure 2 1 
Median cardiac troponin values plotted against tertiles of race duration and baseline systolic 2 
blood pressure a) cTnI 3 hours post-race, b) cTnT 3 hours post-race, c) cTnI 24 hours post-3 
race, d) cTnT 24 hours post-race, n=1002. 4 
 5 




Table 1 1 
Baseline characteristics of subjects included in the study.  2 
 3 
 Total cohort (n=1002) 
Age, years 46.8 (40.1-52.6) 
Males, % 782 (78.2%) 
BMI, kg/m2 25.3 (23.7-27.3) 
Body weight, kg 82.1 (74.6-89.4) 
Systolic blood pressure, mmHg 136 (126-148) 
Diastolic blood pressure, mmHg 79 (73-86) 
Waist circumference, cm 86.0 (80-92) 
Family history of sudden death/early myocardial infarction, n (%) 187 (18.7%) 
History of hypertension, n (%) 23 (2.3%) 
Current smokers, n (%) 13 (1.3%) 
Framingham risk score, %* 1 (0-5)  
   
Physical fitness 
Resting heart rate, beats/min 59 (53-67) 
MET hours per week † 51.3 (31.8-80.0) 
Number of races past 5 y, n (%) 7 (3-15) 
Self-reported maximal heart rate, beats/min 185 (178-193) 
  
Race performance  
Race duration, hours 3.7 (3.4-4.2) 
Maximal heart rate during the race, beats/min 178.0 (170-186) 
Maximal heart rate of estimated maximal heart rate, % 100.4 (96.8-104.4) 
Mean heart rate during the race, beats/min 157.0 (148.0-165.0) 
Mean heart rate of estimated maximal heart rate, % 88.6 (84.5-92.5) 
   
Biomarkers at baseline 
cTnI, ng/L ‡ 1.9 (1.6-3.0) 
cTnT, ng/L § 3.0 (3.0-4.2) 
BNP, pg/mL 13.4 (10.0-21.2) 
CRP, mg/L 0.7 (0.4-1.3) 
Creatinine, umol/L 83.8, SD: 11.7 
eGFR, mL/min/1.73m2 91.3, SD: 12.7 
Total Cholesterol, mmol/L 5.1 (4.6-5.8) 
LDL, mmol/L 3.2 (2.6-3.7) 
HDL, mmol/L 1.5 (1.3-1.7) 
Hemoglobin, g/dL 14.5, SD: 1.0 
 4 
*  Framingham risk score: 10-year risk of death or myocardial infarction.  5 
† MET = Metabolic equivalents (3.5 ml O2/kg/min). Estimated by IPAQ-SF 6 
‡ 40.2 % had cTnI values ≤ 1.6 ng/L (limit of detection) 7 




Table 2 1 
 2 
Bivariate correlations (Spearman’s Rank Correlation) and multiple linear regression models 3 
for cTn at different time-points (n=1002). B signifies the regression coefficient. Variables 4 
included in the multiple regression analysis: gender, age, resting heart rate, baseline systolic- 5 
and diastolic blood pressure, low density lipoprotein (LDL), estimated glomerular filtration 6 
rate (eGFR), body mass index (BMI), race duration, Framingham risk score and baseline cTn 7 
values. A backward variable elimination procedure was used.  8 
 9 









 Rho p-value B p-value  Rho p-value B p-value 
Age, years 0.17 <0.001  Ns  0.30 <0.001  Ns 
Gender, males 0.22 <0.001  Ns  0.26 <0.001 0.110 <0.001 
Resting heart rate, bpm -0.18 <0.001 -0.010 <0.001  -0.14 <0.001 -0.004 0.001 
Systolic BP, mmHg 0.21 <0.001 0.005 0.002  0.19 <0.001 0.002 0.004 
Race duration, hours -0.16 <0.001 -0.088 0.008  -0.10 0.003  Ns 
eGFR, mL/min/1.73m2 -0.10 0.001  Ns  -0.23 <0.001 -0.004 <0.001 
LDL, mmol/L 0.09 0.005  Ns  0.07 0.03 -0.023 0.084 
Framingham risk score, % 0.23 <0.001 0.018 0.004  0.37 <0.001 0.021 <0.001 
BMI, kg/m2 0.10 0.002 0.016 0.035  0.09 0.005  Ns 
Body weight, kg 0.18 <0.001    0.17 <0.001   
Waist circumference, cm 0.14 <0.001    0.17 <0.001   
Diastolic BP, mmHg 0.16 <0.001    0.15 <0.001   
MET hours per week 0.05 0.158    0.06 0.059   
HDL, mmol/L -0.02 0.598    -0.04 0.271   
Endurance training, years 0.12 0.001    0.10 0.005   
Maximal heart rate race, bpm -0.13 0.004    -0.22 <0.001   
% maximal HR of estimated max -0.08 0.069    -0.08 0.052   
Mean HR during race, bpm -0.12 0.006    -0.21 <0.001   
% mean HR of estimated max -0.07 0.116    -0.07 0.083   











         
 
 
         











B p-value  Rho p-value B p-value 
Age, years -0.05 0.094 -0.014 0.001  0.03 0.351 -0.004 0.087 
Gender, males 0.05 0.152 -0.269 0.002  0.16 <0.001  Ns 
Resting heart rate, bpm -0.03 0.382  Ns  -0.07 0.036  Ns 
Systolic BP, mmHg 0.14 <0.001 0.006 <0.001  0.14 <0.001 0.004 <0.001 
Race duration, hours -0.15 <0.001 -0.228 <0.001  -0.25 <0.001 -0.216 <0.001 
eGFR, mL/min/1.73m2 0.03 0.403  Ns  -0.03 0.402  Ns 
LDL, mmol/L -0.02 0.498  Ns  0.09 0.004  Ns 
Framingham risk score, % -0.01 0.73 0.020 0.090  0.09 0.003  Ns 
BMI, kg/m2 0.04 0.225 0.019 0.045  0.02 0.458  Ns 
Baseline cTn, ng/L 0.31 <0.001 0.346 <0.001  0.29 <0.001 0.442 <0.001 
Body weight, kg 0.08 0.008    0.10 0.002   
Waist circumference, cm 0.03 0.309    0.05 0.131   
Diastolic BP, mmHg 0.06 0.053    0.05 0.137   
MET hours per week -0.03 0.438    0.03 0.431   
HDL, mmol/L 0.00 0.998    -0.02 0.550   
Endurance training, years -0.07 0.050    -0.04 0.206   
Maximal heart rate race, bpm 0.10 0.026    0.00 0.917   
% maximal HR of estimated max 0.02 0.606    -0.02 0.62   
Mean HR during race, bpm 0.14 0.001    0.11 0.011   
% mean HR of estimated max 0.07 0.092    0.90 0.048   
 1 





          









 Rho p-value B p-value  Rho p-
value 
B p-value 
Age, years 0.15 <0.001 0.008 0.008  0.16 <0.001  Ns 
Gender, males 0.13 <0.001  Ns  0.30 <0.001 0.092 0.096 
Resting heart rate, bpm -0.08 0.013  Ns  -0.09 0.004  Ns 
Systolic BP, mmHg 0.22 <0.001 0.007 <0.001  0.23 <0.001 0.005 <0.001 
Race duration, hours -0.16 <0.001 -0.142 <0.001  -0.28 <0.001 -0.199 <0.001 
eGFR, mL/min/1.73m2 -0.08 0.015  Ns  -0.09 0.006  Ns 
LDL, mmol/L 0.07 0.026  Ns  0.09 0.004 0.040 0.067 
Framingham risk score, % 0.20 <0.001  Ns  0.37 <0.001  Ns 
BMI, kg/m2 0.09 0.030 0.024 0.010  0.14 <0.001 0.024 <0.001 
Baseline cTn, ng/L 0.51 <0.001 0.765 <0.001  0.44 <0.001 0.637 <0.001 
Body weight, kg 0.14 <0.001    0.22 <0.001   
Waist circumference, cm 0.11 0.001    0.19 <0.001   
Diastolic BP, mmHg 0.14 <0.001    0.14 <0.001   
MET hours per week 0.02 0.533    0.04 0.182   
HDL, mmol/L 0.00 0.973    -0.09 0.007   
Endurance training, years 0.03 0.415    0.02 0.584   
Maximal heart rate race, bpm -0.03 0.444    -0.05 0.241   
% maximal HR of estimated max -0.02 0.640    -0.02 0.638   
Mean HR during race, bpm -0.01 0.850    0.07 0.088   
% mean HR of estimated max 0.02 0.621    0.11 0.009   
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